Atul Mishra1, Ankit Mathur2, Kamal Pathak3, C D S Katoch4, Anurag Khera5. 1. Classified Specialist (Radiology) & Interventional Radiologist, Army Hospital (R&R), Delhi Cantt, India. 2. Classified Specialist (Radiology) & Interventional Radiologist, Command Hospital (Eastern Command), Kolkata, India. 3. Dy Comdt, Command Hospital (Eastern Command), Kolkata, India. 4. Senior Adviser & Head, Dept of Respiratory Medicine, Military Hospital (Cardio Thoracic Centre), Pune 411040, India. 5. Associate Professor, Dept of Community Medicine & Epidemiologist, Armed Forces Medical College, Pune 411040, India.
Abstract
BACKGROUND: Hemoptysis is one of the most alarming condition to both the patients suffering from it and the treating physicians. It is caused due to varied etiologies. One of the emergent and at times life-saving treatment option is by minimally invasive interventional radiological technique of Bronchial Atery Embolization (BAE). The authors aimed to carry out a retrospective analysis of short term efficacy and safety of all patients treated by this technique at a tertiary care thoracic centre. METHODS: A total of 52 patients were included in the study who had a median follow up of 35 days. All these patients were referred for hemoptysis, intractable hemoptysis not controlled by conservative management or massive hemoptysis. An analysis of the underlying etiology, immediate and short term outcomes and complications was made. RESULTS: The study showed Tuberculosis and its sequel (bronchiectasis and chronic fibrotic changes) as the commonest etiology (65%). The BAE showed high short term efficacy (92%) in stopping the hemoptysis with a relatively low complication rate especially of major complications such as spinal cord ischemia (1.9%). The study strengthens the limited Indian data available on the subject and based on its outcome, BAE should be tried in all patients presenting with uncontrollable or massive hemoptysis not getting relief by conservative management alone. CONCLUSION: BAE is a very effective procedure with very less complications for management of massive or uncontrollable hemoptysis.
BACKGROUND: Hemoptysis is one of the most alarming condition to both the patients suffering from it and the treating physicians. It is caused due to varied etiologies. One of the emergent and at times life-saving treatment option is by minimally invasive interventional radiological technique of Bronchial Atery Embolization (BAE). The authors aimed to carry out a retrospective analysis of short term efficacy and safety of all patients treated by this technique at a tertiary care thoracic centre. METHODS: A total of 52 patients were included in the study who had a median follow up of 35 days. All these patients were referred for hemoptysis, intractable hemoptysis not controlled by conservative management or massive hemoptysis. An analysis of the underlying etiology, immediate and short term outcomes and complications was made. RESULTS: The study showed Tuberculosis and its sequel (bronchiectasis and chronic fibrotic changes) as the commonest etiology (65%). The BAE showed high short term efficacy (92%) in stopping the hemoptysis with a relatively low complication rate especially of major complications such as spinal cord ischemia (1.9%). The study strengthens the limited Indian data available on the subject and based on its outcome, BAE should be tried in all patients presenting with uncontrollable or massive hemoptysis not getting relief by conservative management alone. CONCLUSION: BAE is a very effective procedure with very less complications for management of massive or uncontrollable hemoptysis.
Authors: Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson Journal: Clin Infect Dis Date: 2008-02-01 Impact factor: 9.079
Authors: Karen L Swanson; C Michael Johnson; Udaya B S Prakash; Michael A McKusick; James C Andrews; Anthony W Stanson Journal: Chest Date: 2002-03 Impact factor: 9.410
Authors: A Kato; S Kudo; K Matsumoto; T Fukahori; T Shimizu; A Uchino; S Hayashi Journal: Cardiovasc Intervent Radiol Date: 2000 Sep-Oct Impact factor: 2.740
Authors: K Hayakawa; F Tanaka; T Torizuka; M Mitsumori; Y Okuno; A Matsui; Y Satoh; K Fujiwara; T Misaki Journal: Cardiovasc Intervent Radiol Date: 1992 May-Jun Impact factor: 2.740
Authors: A Poyanli; B Acunas; I Rozanes; K Guven; S Yilmaz; A Salmaslioglu; E Terzibasioglu; R Cirpin Journal: Br J Radiol Date: 2007-03-28 Impact factor: 3.039